CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for GlycoMimetics Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

GlycoMimetics Inc
9708 Medical Center Drive
Phone: (240) 243-1201p:240 243-1201 ROCKVILLE, MD  20850  United States Ticker: GLYCGLYC
Business Summary
GlycoMimetics, Inc. is a biotechnology company. The Company has no ongoing operations, is not performing any research and development, and is preserving cash until the contemplated merger and private placement. The Company was developing a pipeline of proprietary glycomimetics, which are small molecules that mimic the structure of carbohydrates involved in important biological processes, to inhibit disease-related functions of carbohydrates such as the roles they play in cancers and inflammation.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202412/31/2024YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board Timothy R.Pearson 56 5/17/2019 3/31/2014
Senior Vice President, Chief Commercial Officer BruceJohnson 56 2/23/2022 2/23/2022
Senior Vice President, Chief Business Officer ChinmayaRath 48 2/1/2023 2/1/2023
Independent Director Patricia S.Andrews 66 6/12/2017 6/12/2017
Independent Director Daniel M.Junius 72 3/17/2016 3/17/2016

Business Names
Business Name
Gemini Merger Sub Corp.
Gemini Merger Sub II, LLC
GLYC

General Information
Number of Employees: 4 (As of 1/31/2025)
Outstanding Shares: 64,513,862 (As of 2/7/2025)
Shareholders: 20
Stock Exchange: NASD
Federal Tax Id: 061686563
Fax Number: (240) 243-1018


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 18, 2025